Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
unknownnot_applicable

Benefit of Hemostatic Sealant in Preservation of Ovarian Reserve

NCT05037552
completednot_applicable

Impact on Ovarian Reserve of Diode Laser vs Bipolar Coagulation of Endometriomas

NCT02350452
completedphase_3

Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix

NCT01857466
completednot_applicable

Comparison Between Two Endoscopic Treatments of Bleeding Internal Hemorrhoids:Band Ligation and Electrocoagulation Probe

NCT00630669

Clinical Trials (4)

Showing 4 of 4 trials
NCT05037552Not Applicable

Benefit of Hemostatic Sealant in Preservation of Ovarian Reserve

Unknown
NCT02350452Not Applicable

Impact on Ovarian Reserve of Diode Laser vs Bipolar Coagulation of Endometriomas

Completed
NCT01857466Phase 3

Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix

Completed
NCT00630669Not Applicable

Comparison Between Two Endoscopic Treatments of Bleeding Internal Hemorrhoids:Band Ligation and Electrocoagulation Probe

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4